Axillary ultrasonography to detect recurrence after sentinel node biopsy in breast cancer

Annals of Surgical Oncology

Volumn 13, Issue 4, 2006, Pages 501-507

  Snider Jr , Howard C ^a   Rubin, Eva ^a   Henson, Rebecca ^a  

^a Baptist Medical Center   (United States)

Author keywords

Axilla; Breast cancer; Sentinel node; Ultrasound

Indexed keywords

ADULT; AGED; ARTICLE; ASPIRATION BIOPSY; BREAST CARCINOMA; CANCER DIAGNOSIS; CANCER PATIENT; CANCER RECURRENCE; CLINICAL EXAMINATION; COMMUNITY HOSPITAL; CONTROLLED STUDY; CYTOLOGY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; ECHOGRAPHY; FOLLOW UP; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; METASTASIS; OCCULT CANCER; RADIOLOGIST; SENTINEL LYMPH NODE BIOPSY; SURGEON; SURGICAL TECHNIQUE;

ADULT; AGED; AGED, 80 AND OVER; AXILLA; BIOPSY, FINE-NEEDLE; BREAST NEOPLASMS; FALSE NEGATIVE REACTIONS; FEMALE; HUMANS; LYMPHATIC METASTASIS; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; SENTINEL LYMPH NODE BIOPSY;

EID: 33644982699     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/ASO.2006.05.015     Document Type: Article

References (45)

1. Krag DN, Weaver DL, Alex JC, Fairbank JT. Surgical resection and radiolocalization of the sentinel lymph node in breast cancer using a gamma probe. Surg Oncol 1993; 2:335-40.
2. Giuliano AE, Kirgan DM, Guenther JM, Morton DL. Lymphatic mapping and sentinel lymphadenectomy for breast cancer. Ann Surg 1994; 220:391-8.
3. Albertini JJ, Lyman G, Cox C, et al. Lymphatic mapping and sentinel node biopsy in the patient with breast cancer. JAMA 1996; 276:1818-22.
4. McMasters KM, Tuttle TM, Carlson DJ, et al. Sentinel node biopsy for breast cancer: a suitable alternative to routine axillary dissection in multi-institutional practice when optimal technique is used. J Clin Oncol 2000; 18:2560-6.
5. Giuliano AE, Jones RC, Brennan M, Statman R. Sentinel lymphadenectomy in breast cancer. J Clin Oncol 1997; 15:2345-50.
6. Snider H, Dowlatshahi K, Fan M, et al. Sentinel node biopsy in the staging of breast cancer. Am J Surg 1998; 176:305-10.
7. Edwards M, Giuliano A, Reintgen D, Tafra L. Consensus statement on guidelines for performance of sentinel lymph node biopsy for breast cancer. Am Soc Breast Surg Q 1998; 6:3.
8. Krag D, Weaver D, Ashikaga T, et al. The sentinel node in breast cancer. A multicenter validation study. N Engl J Med 1998; 339:941-6.
9. Cody HS, Hill AD, Tran KN, et al. Credentialing for breast lymphatic mapping: how many cases are enough? Ann Surg 1999; 229:723-6.
10. Veronesi U. The sentinel node and breast cancer. Br J Surg 1999; 86:1-2.
11. Chung MA, Steinhoff MM, Cady B. Clinical axillary recurrence in breast cancer patients after a negative sentinel node biopsy. Am J Surg 2002; 184:310-4.
12. Schrenk P, Hatzl-Griesenhodfer M, Shamiyeh A, Waynad W. Follow-up of sentinel node negative breast cancer patients without axillary lymph node dissection. J Surg Oncol 2001; 77:165-70.
13. Roumen RM, Kuijt GP, Liem IH, van Beek MW. Treatment of 100 patients with sentinel node-negative breast cancer without further axillary dissection. Br J Surg 2001; 88:1639-43.
14. Giuliano AE, Haigh PI, Brennan MP, et al. Prospective observational study of sentinel lymphadenectomy without future axillary dissection in patients with sentinel node-negative breast cancer. J Clin Oncol 2000; 18:2553-9.
15. Veronesi U, Galimberti V, Zurrida S, et al. Sentinel lymph node biopsy as an indicator for axillary dissection in early breast cancer. Eur J Cancer 2001; 37:454-8.
16. Blanchard DK, Donohue JH, Reynolds C, Grant CS. Relapse and morbidity in patients undergoing sentinel lymph node biopsy alone or with axillary dissection for breast cancer. Arch Surg 2003; 138:482-8.
17. Guenther JM, Hansen NM, DiFronzo LA, et al. Axillary dissection is not required for all patients with breast cancer and positive sentinel nodes. Arch Surg 2003; 138:52-6.
18. Fant JS, Grand MD, Knox SM, et al. Preliminary outcome analysis in patients with breast cancer and a positive sentinel lymph node who declined axillary dissection. Ann Surg Oncol 2003; 10:126-30.
19. Cutler SJ, Connelly RE. Mammary cancer trends. Cancer 1969; 23:767-71.
20. Fisher ER, Gregorio RM, Redmond C, et al. Pathologic findings from the National Surgical Adjuvant Breast Project (protocol No. 4). Am J Clin Pathol 1976; 65:439-44.
21. Smart CR, Myers MH, Gloeckler LA. Implications from SEER data on breast cancer management. Cancer 1978; 41:787-9.
22. Blum A, Schlagenhauff B, Stroebel W, et al. Ultrasound examination of regional lymph nodes significantly improves early detection of locoregional metastases during the follow-up of patients with cutaneous melanoma. Cancer 2000; 88:2534-9.
23. Klimberg VS, Rubio IT, Henry R, et al. Subareolar versus peritumoral injection for location of the sentinel lymph node. Ann Surg 1999; 229:860-5.
24. Kern KA. Sentinel lymph node mapping in breast cancer using subareolar injection of blue dye. J Am Coll Surg 1999; 189:539-45.
25. McMasters KM, Wong SL, Martin RC, et al. Dermal injection of radioactive colloid is superior to peritumoral injection for breast cancer sentinel lymph node biopsy: results of a multi-institutional study. Ann Surg 2001; 233:676-87.
26. Boolbol SK, Fey JV, Borgen PI, et al. Intradermal isotope injection: a highly accurate method of lymphatic mapping in breast carcinoma. Ann Surg Oncol 2001; 8:20-4.
27. Martin RCG, Derossis AM, Fey J, et al. Intradermal isotope injection is superior to intramammary in sentinel node biopsy for breast cancer. Surgery 2001; 130:432-8.
28. Kim HJ, Heerdt AS, Cody HS III, et al. Sentinel lymph node drainage in multicentric breast cancers. Breast J 2002; 8:356-61.
29. Tousimis E, Van Zee KJ, Fey JV, et al. The accuracy of sentinel lymph node biopsy in multicentric and multifocal invasive breast cancers. J Am Coll Surg 2003; 197:529-35.
30. Yang WT, Ahuja A, Tang A, Suen M, King W, Metrewell C. High resolution sonographic detection of axillary lymph node metastases in breast cancer. J Ultrasound Med 1996; 15:241-6.
31. Bonnema J, van Geel AN, van Ooijen B, et al. Ultrasound-guided aspiration biopsy for detection of nonpalpable axillary node metastases in breast cancer patients: new diagnostic method. World J Surg 1997; 21:270-4.
32. Krishnamurthy S, Sneige N, Bedi DG, et al. Role of ultrasound-guided fine-needle aspiration of indeterminate and suspicious axillary lymph nodes in the initial staging of breast carcinoma. Cancer 2002; 95:982-8.
33. Kuenen-Boumeester V, Menke-Pluymers M, de Kanter AY, Obdeijn IM, Urich D, Der Var Kwast TH. Ultrasound-guided fine needle aspiration cytology of axillary lymph nodes in breast cancer patients. A preoperative staging procedure. Eur J Cancer 2003; 39:170-4.
34. Deurloo EE, Tanis PJ, Gilhuijs KG, et al. Reduction in the number of sentinel lymph node procedures by preoperative ultrasonography of the axilla in breast cancer. Eur J Cancer 2003; 39:1068-73.
35. Sapino A, Cassoni P, Zanon E, et al. Ultrasonographically-guided fine-needle aspiration of axillary lymph nodes: role in breast cancer management. Br J Cancer 2003; 88:702-6.
36. Oruwari JU, Chung MA, Koelliker S, Steinhoff MM, Cady B. Axillary staging using ultrasound-guided fine needle aspiration biopsy in locally advanced breast cancer. Am J Surg 2002; 184: 307-9.
37. Turner RR, Ollila DW, Krasne DL, Giuliano AE. Histopathologic validation of the sentinel lymph node hypothesis for breast carcinoma. Ann Surg 1997; 226:276-8.
38. Chung MA, Steinhoff MM, Cady C. Clinical axillary recurrence in breast cancer patients after a negative sentinel node biopsy. Am J Surg 2002; 184:310-4.
39. Blanchard DK, Donohue JH, Reynolds C, Grant CS. Relapse and morbidity in patients undergoing sentinel lymph node biopsy alone or with axillary dissection for breast cancer. Arch Surg 2003; 138:482-8.
40. Reitsamer R, Peintinger F, Prokop E, Menzel C, Cimpoca W, Rettenbacher L. Sentinel lymph node biopsy alone without axillary lymph node dissection - follow-up of sentinel lymph node negative breast cancer patients. Eur J Surg Oncol 2003; 29:221-3.
41. Jeruss JS, Winchester DJ, Sener SF, et al. Axillary recurrence following sentinel node biopsy. Ann Surg Oncol 2004; 11:S58.
42. Smidt ML, Janssen CMM, Kuster DM, Bruggink EDM, Strobbe LJA. Axillary recurrence after a negative sentinel node biopsy for breast cancer: incidence and clinical significance. Ann Surg Oncol 2005; 12:29-33.
43. Naik AM, Fey J, Gemignani M, et al. The risk of axillary relapse after sentinel lymph node biopsy for breast cancer is comparable with axillary lymph node dissection. Ann Surg 2004; 240:462-71.
44. Schlembach PJ, Buchholz TA, Ross MI, et al. Relationship of sentinel and axillary level I-II lymph nodes to tangential fields used in breast irradiation. Int J Radiat Oncol Biol Phys 2001; 51:671-8.
45. Van Zee KJ, Manasseh DM, Bevilacqua JC, et al. A nomogram for predicting the likelihood of additional nodal metastases in breast cancer patients with a positive sentinel node biopsy. Ann Surg Oncol 2003; 10:1140-51.